Clinical and Economic Efficiency of Vaccination in a Pneumococcal 13-Valent Conjugate Vaccine in Patients with Chronic Bronchitis at a Young Age
The high prevalence of chronic bronchitis (CB) among young people, and significant pharmaco-economic costs of health care for treatment of this disease actualizes the search for new solutions for the prevention of exacerbations. The goal is to prove the clinical and economic efficacy of vaccination...
Saved in:
Main Authors: | G. L. Ignatova, I. A. Zakharova, V. N. Antonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2017-04-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/248 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIENCE OF APPLICATION AND SAFETY ASSESSMENT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN UNDER-5 CHILDREN
by: M. V. Fedoseenko, et al.
Published: (2014-09-01) -
Factors that Influence the Coverage of Vaccination against Pneumococcal Infections of Children up to 1 Year Old of Age at the Starting Phase of Vaccination
by: N. N. Filatov, et al.
Published: (2017-06-01) -
PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01) -
Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia
by: A. V. Rudakova, et al.
Published: (2014-09-01) -
Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children
by: S. M. Kharit, et al.
Published: (2016-12-01)